Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Aug 20.
Published in final edited form as: Sci Total Environ. 2022 Apr 29;835:155596. doi: 10.1016/j.scitotenv.2022.155596

Associations between social, biologic, and behavioral factors and biomarkers of oxidative stress during pregnancy: Findings from four ECHO cohorts

Stephanie M Eick a,*, Sarah Dee Geiger b,c, Akram Alshawabkeh d, Max Aung e, Emily Barrett f, Nicole R Bush g,h, José F Cordero i, Kelly K Ferguson j, John D Meeker k, Ginger L Milne l, Ruby HN Nguyen m, Amy M Padula n, Sheela Sathyanarayana o, Barrett M Welch j, Susan L Schantz b,p, Tracey J Woodruff n, Rachel Morello-Frosch n,q,**, on behalf of program collaborators for Environmental influences on Child Health Outcomes
PMCID: PMC9177811  NIHMSID: NIHMS1803455  PMID: 35490822

Abstract

Background:

Lower socioeconomic status (SES) and elevated psychosocial stress are known contributors to adverse pregnancy outcomes; however, biological mechanisms linking these factors to adverse pregnancy outcomes are not well-characterized. Oxidative stress may be an important, yet understudied mechanistic pathway. We used a pooled study design to examine biological, behavioral, and social factors as predictors of prenatal oxidative stress biomarkers.

Methods:

Leveraging four pregnancy cohorts from the Environmental influences on Child Health Outcomes (ECHO) Program spanning multiple geographic regions across the United States (U.S.) (N=2,082), we measured biomarkers of oxidative stress in urine samples at up to three time points during pregnancy, including 8-isoprostane-prostaglandin F (8-iso-PGF), its major metabolite, 2,3-dinor-5,6-dihydro-15-F2t-isoprostane, and prostaglandin F (PGF). Maternal age, pre-pregnancy body mass index, marital/partnered status, parity, and smoking status were included as biological and behavioral factors while race/ethnicity, maternal education, and stressful life events were considered social factors. We examined associations between each individual biological, behavioral, and social factor with oxidative stress biomarkers using multivariable-adjusted linear mixed models.

Results:

Numerous biological, behavioral, and social factors were associated with elevated levels of 8-iso-PGF, its major metabolite, and PGF. Pregnant people who were current smokers relative to non-smokers or had less than a high school education relative to a college degree had 9.23% (95% confidence interval [CI]=−0.92%, 20.4%) and 11.1% (95% CI=−1.94%, 25.8%) higher levels of 8-iso-PGF, respectively.

Conclusions:

Oxidative stress biomarkers are elevated among pregnant people with higher socioeconomic disadvantage and may represent one pathway linking biological, behavioral, and social factors to adverse pregnancy and child health outcomes, which should be explored in future work.

Keywords: oxidative stress, pregnancy, isoprostane, social determinants

Graphical abstract

graphic file with name nihms-1803455-f0001.jpg

1. Introduction

Lower socioeconomic status (SES) and higher levels of psychosocial stressors are well-known contributors to adverse pregnancy outcomes.1,2 Across the United States (U.S.) and globally, large disparities in the rates of adverse birth outcomes, including preterm birth and lower birth weight, persist across economic classes and racial and ethnic groups.3,4 Structural inequalities and other social factors often underlie these observed health disparities,2 as factors such as differences in education, the built environment, or experiences of racism may increase the exposure and susceptibility of an individual to adverse outcomes.5 Additionally, the same populations who face structural inequalities are often disproportionately exposed to the highest level of environmental hazards, which may also increase the risk of adverse pregnancy outcomes.611

Despite high rates of adverse pregnancy outcomes and their high social cost, the biologic pathways linking social and behavioral factors to adverse birth outcomes are not well-characterized. While the hypothalamic-pituitary-adrenal (HPA) axis is hypothesized to be a key contributor,12 oxidative stress may represent an alternative (or complementary) unifying mechanism. 8-isoprostane-prostaglandin F (8-iso-PGF), a measure of lipid peroxidation, is widely considered to be the ‘gold standard’ biomarker of oxidative stress.13,14 8-iso-PGF is elevated in response to numerous environmental chemical and non-chemical stressors that may be reflective of a socioeconomic disadvantage, such as low educational attainment and smoking status.1519 Prior studies also suggest that certain biological factors, such as obesity, predispose individuals to elevated levels of 8-iso-PGF20 Further, prenatal levels of 8-iso-PGF are increased among those who go on to experience adverse birth outcomes and pregnancy-related complications.2123 However, most prior studies have been limited by relatively small sample sizes, restricted geographic locations, and racially homogenous study populations, which do not reflect the diversity of the U.S. Thus, better understanding determinants of oxidative stress during pregnancy may help clinicians and public health practitioners better target interventions aimed at improving pregnancy outcomes.

In the current analysis, we used harmonized data from four pregnancy cohorts participating in the National Institutes of Health (NIH) Environmental influences on Child Health Outcomes (ECHO) Program.24 Our combined study population includes a demographically diverse group of predominately Latina and White pregnant people with repeated measures of oxidative stress across gestation. We measured 8-iso-PGF, as well as its major metabolite, as biomarkers of oxidative stress. The 8-iso-PGF metabolite was included because it may be a superior biomarker than its parent compound when measured in urine.25 We additionally included a third oxidative stress marker, prostaglandin-F (PGF), as it is enzymatically derived and reflective of inflammation pathways. When measured in combination with 8-iso-PGF, PGF may allow us to disentangle the proportion of 8-iso-PGF that is derived from enzymatic and non-enzymatic lipid peroxidation pathways.26 We hypothesized that certain biological and behavioral factors (e.g., increasing maternal age, being overweight or obese, increasing parity, or being a current smoker) would lead to increased levels of these biomarkers. We similarly hypothesized that oxidative stress biomarkers would be elevated among those who experience structural inequalities or social factors reflecting lower SES (e.g., persons of color, lower educational attainment, and experiences of stressful life events). Our study is the largest to date that examines behavioral, biological, and social factors in relation to prenatal oxidative stress.

2. Methods

2.1. Study Population

Our study population included four cohorts participating in the NIH ECHO Program: Chemicals in Our Bodies (CIOB—San Francisco, California), Illinois Kids Development Study (IKIDS-Champaign-Urbana, Illinois), Puerto Rico Testsite for Exploring Contamination Threats (PROTECT), and The Infant Development and Environment Study (TIDES- Rochester, New York; San Francisco, California; Seattle, Washington; and Minneapolis, Minnesota). Our final sample size included 2,082 participants: 229 from CIOB, 230 from IKIDS, 866 from PROTECT, and 757 from TIDES (Figure S1). Together, these cohorts represent a geographically and demographically diverse study population. These cohorts were invited to participate in this combined analysis because they had measures of urinary levels of 8-iso-PGF, the major 8-iso-PGF metabolite, and PGF in a subset of participants at the time of analysis. Detailed information on recruitment and data collection methods for each cohort is provided elsewhere.2729 Briefly, for all studies, participants were recruited during pregnancy and were eligible for inclusion if they were not pregnant with multiples and were at least 18 years of age. Each of these cohorts’ protocols was reviewed and approved by their local institutional review boards, and all cohort participants provided written, informed consent.

2.2. Biological and Behavioral Factors

Biological and behavioral factors included maternal age, pre-pregnancy body mass index (BMI; kg/m2), parity, and smoking status. This information was obtained by self-reported interview questionnaire administered during pregnancy or from the medical record.

2.3. Social Factors

We included maternal race/ethnicity, educational attainment, marital status, and self-reported experiences of stressful life events (SLEs) as social factors. While belonging to a certain racial or ethnic group should not predispose one to elevated levels of oxidative stress, people of color often experience higher levels of racism and structural discrimination relative to White individuals.30 Information on perceived racism was not available in our analytic sample, and we have included self-identified race/ethnicity as a proxy for experiences of racial discrimination.

All cohorts asked about the occurrence of five SLEs within the last year (CIOB) or during pregnancy (IKIDS, PROTECT, TIDES) using a self-reported interview questionnaire.16,27,31 Across all cohorts, stressful life events included: participant or participant’s partner lost their job, a close family member was ill or hospitalized, participant or participant’s partner experienced legal or financial trouble, participant experienced relationship problems with their partner, or someone close to the participant died. We created a binary measure of SLEs where pregnant people reporting no SLEs were categorized as “none” and those reporting at least one SLE were categorized as having experienced “any.”

2.4. Oxidative Stress Biomarkers

Urine samples were collected at three time points in PROTECT (mean 18.2, 23.6, and 26.9 weeks gestation), two time points in both CIOB (mean 20.2 and 31.0 weeks gestation) and IKIDS (mean 16.2 and 23.3 weeks gestation), and once in TIDES (mean 32.7 weeks gestation), and were frozen at −80°C prior to analysis. For all cohorts, the Eicosanoid Core Laboratory at Vanderbilt University Medical Center analyzed urinary levels of 8-iso-PGF, 2,3-dinor-5,6-dihydro-15-F2t-isoprostane (8-iso-PGF metabolite), and PGF. Biomarker analysis of the PROTECT and TIDES urine samples was conducted using stable isotype dilution gas chromatography-negative ion chemical ionization mass spectrometry; this method has been described in detail elsewhere.32 Briefly, this method requires a C18 Sep-Pak column for solid-phase extraction, a thin-layer chromatography purification, and chemical derivation. During analyses, samples are thawed, and 0.25 ml urine is diluted in 10 ml pH 3 water and acidified to pH 3 using 1 N HCl prior to extraction. Analysis for urine samples obtained from CIOB and IKIDS participants was done using liquid chromatography–mass spectrometry. The Eicosanoid Core Laboratory measures quality control (QC) samples with each batch, and urine is aliquoted in large batches to ensure that the same QCs are used for every batch for at least a year. Levels of F2-Isoprostanes are also measured in these samples to track variation over time.

As an exploratory sensitivity analysis, we additionally quantified the proportions of 8-iso-PGF derived from each of the respective pathways using the ratio of 8-iso-PGF to PGF.26 The chemical fraction captures non-enzymatic lipid peroxidation as a result of oxidative stress while the enzymatic fraction is generated from prostaglandin-endoperoxide synthases and is more reflective of inflammation. The chemical and enzymatic fractions were calculated using a custom interface for the R package “Constrained Linear Mixed Effects (CLME).”26

To account for urinary dilution, all biomarker concentrations were corrected for specific gravity (SpG) using the equation Oxc=Ox[(SpGMedian-1)/SpG-1], where SpGMedian is the SpG population median for each cohort, Ox is the measured oxidative stress biomarker concentration, and Oxc is the SpG-corrected measure. The constant SpGmedian was 1.019 for PROTECT, 1.012 for CIOB, 1.015 for IKIDS, and 1.014 for TIDES. All SpG-corrected biomarker concentrations were right-skewed and natural log-transformed for analyses. Oxidative stress biomarker concentrations below the limit of detection (LOD) were imputed using LOD/2.

2.5. Statistical Analysis

We examined the distribution of oxidative biomarker concentrations across biological, behavioral, and social factors using geometric means and geometric standard deviations (SD). We additionally utilized generalized additive mixed models with a random intercept for participant ID and a smoothing term for gestational age at sample collection to graphically depict levels of measured oxidative stress biomarkers across gestation. Intraclass correlation coefficients (ICC) were calculated to examine variability in biomarker concentrations across repeated measures. ICC values range from 0 to 1, where ICC values closest to 1 indicate perfect reliability and values closer to 0 indicate greater variability. ICC values between 0.4 and 0.75 indicate good reliability.33 Because oxidative stress biomarkers were only available at one time point in TIDES, this cohort was excluded from ICC calculations.

For our repeated measures analysis, we used linear mixed models to examine associations between each individual biological, behavioral, and social factor and biomarker concentrations. Oxidative stress biomarkers were treated as separate outcomes. Models included a fixed effect categorical indicator for study cohort, a smoothed term for gestational age at sample collection, and a random intercept for participant ID. Covariates included in models were chosen via a directed acyclic graph (DAG) that was informed via a literature review (Figure S2). Models evaluating maternal education, marital status, maternal age, or pre-pregnancy BMI as primary exposures were only adjusted for cohort and gestational age at sample collection. In models where parity was the exposure of interest, we additionally adjusted for maternal age. When race/ethnicity and smoking status were the exposures, we additionally controlled for education and marital status as indicators of SES. When the SLE indicator was the exposure, we included maternal age, marital status, education, and race/ethnicity. A complete case analysis was used for all multivariable models. The final sample size for all models is presented in Table S1.

We conducted numerous sensitivity analyses to determine if any associations could be attributed to underlying differences (i.e., heterogeneity) across cohorts. We first examined associations stratified by cohort to compare cohort-specific associations. Second, we conducted an analysis excluding participants from the PROTECT cohort given that PROTECT contributed the largest number of participants and experiences of certain social factors in Puerto Rico may not be representative of experiences in the mainland U.S. Third, we restricted our analysis to only include the latest oxidative stress measurement for each cohort. Next, we compared our primary model that used a fixed effect for cohort to a model that used a random effect for cohort. When both approaches give similar estimates, it indicates that heterogeneity across cohorts is minimal.34 Lastly, because specific gravity may also be influenced by other covariates (e.g., age, race/ethnicity, BMI), we separately standardized SpG concentration using an established covariate-adjustment approach.35,36 Using this approach, we applied the equation Oxc=Ox[(SpGpredict-1)/SpG-1], where SpGpredict corresponds to the predicted specific gravity concentration based on a prediction model of specific gravity.35,36 We included the covariate standardized SpG corrected biomarkers as outcomes in our linear mixed models and compared effect estimates to those obtained in our primary analysis, which corrected oxidative stress biomarkers using the sample mean of SpG.

All statistical analyses were conducted on complete cases using R version 4.0.1.

3. Results

The majority of participants included in this analysis were married (65%), had a normal pre-pregnancy BMI (51%), and had a college (40%) or graduate (30%) degree (Table 1). Approximately half of our study population were Latina; 5% were Black; 5% were Asian or Pacific Islander; 2% were multi-racial; and nearly 40% were White. The high percentage of Latinas was attributed to the inclusion of the PROTECT cohort, as nearly all PROTECT participants self-identified as Latina (Table S2). In the overall analytic sample, 34% experienced at least one stressful life event. The prevalence of stressful life events varied widely across cohorts, with 62% of CIOB participants experiencing stressful life events compared with only 22% of IKIDS participants (Table S2).

Table 1.

Distribution of biological, behavioral, and social factors in the overall study population (N=2,082).

N (%)
Biological and behavioral factors
Maternal age (years)
 18–24 458 (22%)
 25–29 531 (26%)
 30–34 616 (30%)
 ≥35 429 (21%)
 Missing 48 (2.3%)
Pre-pregnancy BMI (kg/m2)
 Underweight 88 (4%)
 Normal 1069 (51%)
 Overweight 466 (22%)
 Obese 394 (19%)
 Missing 65 (3.1%)
Parity
 0 900 (43%)
 1+ 991 (48%)
 Missing 191 (9.2%)
Current smoker
 No 1929 (93%)
 Yes 76 (4%)
 Missing 77 (3.7%)
Social factors
Maternal race/ethnicity
 White 781 (38%)
 Black 114 (5%)
 Asian/Pacific Islander 108 (5%)
 Latina 999 (48%)
 Other/multi-racial 49 (2%)
 Missing 31 (1.5%)
Maternal education
 <High school 145 (7%)
 High school or some college 459 (22%)
 College degree 832 (40%)
 Graduate degree 628 (30%)
 Missing 18 (0.9%)
Marital status
 Married 1347 (65%)
 Living together 396 (19%)
 Single 325 (16%)
 Missing 14 (0.7%)
Stressful life events
 None 1251 (60%)
 Any 701 (34%)
 Missing 130 (6.2%)

BMI, body mass index.

The distribution of oxidative stress biomarkers is presented in Table 2. All biomarkers were detected in nearly 100% of participants (Table S3). The overall geometric means were 1.34 for 8-iso-PGF (geometric SD=2.01), 0.9 for the 8-iso-PGF metabolite (geometric SD=3.1), and 2.31 for PGF (geometric SD=2.44). Among individual cohorts, the geometric mean of 8-iso-PGF (geometric mean=1.13) was highest for IKIDS, whereas the geometric mean of the metabolite and PGF were highest in CIOB and PROTECT, respectively (geometric mean=2.14 and 2.84, correspondingly) (Table S3). ICC values for 8-iso-PGF indicated moderate reliability (ICC=0.55, 95% confidence interval [CI]=0.51, 0.59), whereas the values for the 8-iso-PGF metabolite and PGF were less stable (ICC=0.24, 95% CI=18, 0.29; ICC=0.14, 95% CI=0.08, 0.19, respectively). Levels of 8-iso-PGF and the 8-iso-PGF metabolite increased slightly during mid-gestation, whereas levels of PGF declined across pregnancy (Figure 1).

Table 2.

Distribution of urinary levels of oxidative stress biomarkers corrected with specific gravity (ng/mL).

N Geometric mean (Geometric SD) Percentile
5 25 50 75 95
Measured
8-iso-PGF
 Overall 3255 1.34 (2.01) 0.43 0.90 1.43 2.12 3.59
 Average 2082 1.23 (1.94) 0.41 0.82 1.29 1.91 3.29
8-iso-PGF metabolite
 Overall 3251 0.90 (3.1) 0.07 0.60 0.91 1.42 5.4
 Average 2081 0.83 (2.64) 0.2 0.55 0.83 1.28 3.88
PGF
 Overall 3255 2.31 (2.44) 0.51 1.56 2.55 3.98 7.35
 Average 2082 2.25 (2.12) 0.59 1.51 2.39 3.61 6.71
Derived
8-iso-PGF chemical
 Overall 3255 0.91 (2.47) 0.19 0.56 1.01 1.66 3.17
 Average 2082 0.8 (2.41) 0.17 0.5 0.87 1.48 2.86
8-iso-PGF enzymatic
 Overall 3255 0.13 (9.55) 0 0.09 0.32 0.56 1.09
 Average 2082 0.14 (6.49) 0 0.06 0.27 0.49 0.96

Overall distributions are calculated using all subject-specific values. Average values are calculated using biomarker concentrations averaged across all available time points for each participant. 8-iso-PGF2α, 8-isoprostaneprostaglandin F2α; PGF2α, prostaglandin F2α; SD, standard deviation.

Figure 1.

Figure 1.

Predicted values (95% confidence intervals) of specific gravity-corrected urinary oxidative stress biomarker concentrations by gestational age at sample collection obtained from generalized additive mixed models with a random intercept for participant ID.

In our repeated measures analysis using linear mixed models (Figure 2; Table S4), we observed that 8-iso-PGF levels were higher among those who were single relative to married (% difference=21.5, 95% CI=14.2, 29.3), current smokers relative to non-smokers (% difference=11.1, 95% CI=−1.94, 25.8), and overweight (% difference=15.4, 95% CI=9.42, 21.7) or obese (% difference=34.4, 95% CI=26.9, 42.3) relative to a normal weight. Effect estimates were similar when the 8-iso-PGF metabolite and PGF were the outcomes of interest. Compared with White participants, Black participants had 24.2% higher 8-iso-PGF (95% CI=−0.23, 54.6), whereas those who were Asian or Pacific Islander had 34.9% higher levels of the major 8-iso-PGF metabolite (95% CI=11.6, 63.2). When examining the chemical and enzymatic fractions of 8-iso-PGF, associations were consistently strongest for the chemical fraction, whereas associations with the enzymatic fraction were null (Table S4). This indicates that increases in 8-iso-PGF occurring as a result of biological, behavioral, and social factors were through chemical free radical lipid peroxidation, as opposed to enzymatic inflammatory pathways.

Figure 2.

Figure 2.

Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity–corrected oxidative stress biomarker concentrations (ng/mL) in relation to biological, behavioral, and social factors.

Sample sizes for all models are provided in Table S1. All models are adjusted for cohort and include a random intercept for participant ID and smoothed term for gestational age at study visit. Models that include race/ethnicity and current smoker as exposures are additionally adjusted for marital status and education. A model including parity as the exposure is additionally adjusted for maternal age. A model that includes stressful life events as the exposure is additionally adjusted for maternal age, race/ethnicity, education, and marital status. BMI, body mass index.

In our supplemental analysis, models adjusted for cohort alone similarly showed that levels of 8-iso-PGF and the 8-iso-PGF metabolite were elevated among those who were overweight or obese, between 18–24 years of age, and unmarried relative to reference groups (Table S5). When stratifying by cohort, experiencing stressful life events was associated with a significant increase in 8-iso-PGF within the PROTECT cohort only (% difference=6.97, 95% CI=1.08, 13.2), as has been previously reported (Table S6).16,37 Effect estimates restricted to CIOB and IKIDS had wide CIs, which reflected the relatively small sample sizes in these cohorts. Associations between the 8-iso-PGF metabolite and PGF and biological, behavioral, and social factors were similar to those observed for 8-iso-PGF (data not shown). When restricting to only the latest oxidative stress biomarker measurement, point estimates were similar to our primary analysis (Table S7), although confidence intervals were less precise. In a leave-one-out analysis removing the PROTECT cohort, the positive associations between 8-iso-PGF and lower education (having less than a high school education relative to a high school degree) and younger age (18–24 years of age relative to 25–29) were slightly attenuated (Table S8). However, effect estimates were still in the same direction as in our main analysis. The associations between biological, behavioral, and social factors and 8-iso-PGF were nearly identical when cohort was included as a random effect compared with a fixed effect (Table S9). Associations between behavioral, biological, and social factors and covariate-adjusted SpG-corrected oxidative stress biomarker concentrations were similar to those observed when oxidative stress biomarkers were corrected for SpG alone (data not shown).

4. Discussion

In the present analyses, we utilized data from four prospective birth cohorts enrolled in the NIH ECHO Program to examine associations between behavioral, biological, and social factors and prenatal oxidative stress. Our results demonstrate that many of these factors were associated with elevated levels of 8-iso-PGF and its major metabolite, 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. These associations were strongest with the proportion of 8-iso-PGF generated through chemical lipid peroxidation, indicating that the associations we observed with 8-iso-PGF may be attributable to oxidative stress rather than inflammation.

Our findings that 8-iso-PGF levels are sensitive to biological, behavioral, and social factors replicate and extend prior research in this area. Among a group of pregnant people in Boston, 8-iso-PGF levels were higher among those who self-identified as Black and other/multi-racial relative to White, and among those with a pre-pregnancy BMI ≥30 kg/m2.18 That study also observed inverse associations between educational attainment and 8-iso-PGF,18 which was observed in our study. Among non-pregnant populations, recent meta-analyses have found that 8-iso-PGF levels are increased among smokers relative to non-smokers and that obesity is associated with permanently increased oxidative stress in adults.19,20 In our study, the strongest associations observed were with smoking and obesity, highlighting two potentially modifiable risk factors to lower levels of oxidative stress.

Oxidative stress may be one pathway linking structural inequalities to adverse health outcomes among pregnant people and their offspring. Within the TIDES cohort, we previously showed that increasing levels of 8-iso-PGF and its metabolite were associated with lower birthweight and increased childhood weight at age 4.38 Numerous studies have further shown that elevated levels of 8-iso-PGF and its metabolite are associated with increased odds of preterm birth.21,22,3942 Some evidence further suggests that 8-iso-PGF levels are also elevated among those who develop preeclampsia relative to normotensive pregnancies.23 Higher 8-iso-PGF and 8-OH-dG, a marker of DNA damage, were also associated with lower scores on a measure of suboptimal health status within a hospital-based study of pregnant people in Ghana.43

A novel aspect of our study was our exploratory analysis that utilized the ratio of 8-iso-PGF to PGF to examine fractions of 8-iso-PGF. This represents an advancement from prior studies that have interpreted 8-iso-PGF solely as an indicator of oxidative stress (i.e., derived from lipid peroxidation pathways). However, we also acknowledge that the equations described by van ‘t Erve et al,44 which allowed us to estimate the relative contribution of both enzymatic and chemical lipid peroxidation to the formation of 8-iso-PGF were developed from animal studies. Preliminary findings in humans suggest that only a small amount of 8-iso-PGF is produced via enzymatic lipid peroxidation.45 Nonetheless, recent work indicates that environmental chemical and non-chemical stressors have diverse associations with 8-iso-PGF fractions. For example, within the TIDES and PROTECT cohorts, phthalate metabolites primarily lead to increases in the chemical fraction of 8-iso-PGF, reflecting increases in ‘true’ oxidative stress derived from the lipid peroxidation pathway.15,46 We similarly observed that stressful life events were associated with a modest increase in the chemical fraction and a non-significant decrease in the enzymatic fraction (indicative of inflammation) in our study. This suggests that chemical and non-chemical stressors may be more strongly linked to 8-iso-PGF derived from free radical, non-enzymatic pathways. Taken together, this underscores the importance of differentiating between the 8-iso-PGF fractions and analyzing associations separately, as the underlying physiologic pathways may be unique.

Our results should be interpreted in light of study limitations. The different cohorts included in our analytic sample assessed stressful life events using different scales with different timeframes (including year prior to pregnancy versus during the current pregnancy period only), which may have resulted in exposure misclassification. We also had no indicator for severity of stressors or measures of stress in childhood or in the years leading up to the current pregnancy, which may have a stronger effect on 8-iso-PGF than our stressful life events measure, as prior work suggests that a history of childhood maltreatment or experiencing intimate partner violence is associated with higher levels of 8-iso-PGF.47,48 We did not have a measure of perceived discrimination, and we utilized race/ethnicity as a proxy. A study of over 3,700 adults in Maryland showed that self-reported racial discrimination was associated with higher levels of red blood cell oxidative stress, and associations were strongest for Black adults (ages 30–64).49 Within the context of our particular study, utilizing race/ethnicity as a proxy may not be applicable for Latinas, as the majority of Latina participants were enrolled in the PROTECT cohort and experiences of Latinas living in Puerto Rico are different than those of participants living in the mainland U.S. Additionally, other biological markers of stress and other measures of oxidative stress, including other 8-iso-PGF metabolites, were not measured in our study population and would be important to consider in future work. Further, while we did utilize the 8-iso-PGF ratio formula to derive chemical and enzymatic fractions, allowing us to differentiate between oxidative stress and inflammation, it would be worthwhile to explore inflammatory cytokines as well. We did not make any adjustment for multiple comparisons, which may increase the likelihood of chance findings. However, we focused the interpretation of our results on identifying consistent patterns as opposed to specific point estimates.50 Importantly, adjusting for multiple comparisons is not always necessary in exploratory observational studies, as it may increase the probability of type II error due to low statistical power.50 Lastly, while we did adjust for known covariates using a DAG, as with all observational studies, we cannot rule out the possibility of residual confounding.

Despite these limitations, our study has many strengths. First, capitalizing on the ECHO Program, we had a large sample size of over 2,000 pregnant people spanning multiple geographic regions in the continental U.S. and Puerto Rico. These cohorts had repeated measures of oxidative stress across pregnancy, robust information on covariates, and together provided a study population that was racially and ethnically diverse. The results from our study provide important insights into demographically diverse pregnant populations that are not routinely included in environmental epidemiologic studies. Additionally, our analysis included 8-iso-PGF, which is considered to be the ‘gold standard’ biomarker of oxidative stress.13 8-iso-PGF is robust to dietary lipid intake51,52 and on a population level, 8-iso-PGF levels in a spot urine sample are similar to what is observed in a 24-hour fasting sample.53 Our biomarkers were also measured in urine, which is preferred over plasma, as samples are not subject to auto-oxidation during storage.54 Oxidative stress biomarkers were also measured using highly specific mass spectrometry methods, which is preferred over immunoassay.55

5. Conclusions

Our study is the largest to date examining behavioral, biological, and social factors in relation to prenatal oxidative stress. We found that these factors were associated with elevated levels of oxidative stress, which highlights one potential pathway linking structural inequalities to adverse pregnancy and maternal health outcomes. Our study adds to the literature characterizing contributors to elevated prenatal oxidative stress.

Supplementary Material

1

Figure S1. Flowchart indicating participant selection into final analytic sample.

Figure S2. Directed acyclic graph for the relationships between biological, behavioral, and social factors and biomarkers of oxidative stress.

Table S1. Sample size across individual exposure-outcome combinations for adjusted repeated measures analysis.

Table S2. Distribution of biological, behavioral, and social factors across individual cohorts.

Table S3. Distribution of urinary levels of subject-specific oxidative stress biomarkers corrected with specific gravity (ng/mL) across individual cohorts.

Table S4. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected oxidative stress biomarker concentrations (ng/mL) in relation to biological, behavioral, and social factors.

Table S5. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected oxidative stress biomarker concentrations (ng/mL) in relation to biological, behavioral, and social factors. Models are minimally adjusted for cohort.

Table S6. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected 8-iso-PGF2α (ng/mL) in relation to biological, behavioral, and social factors stratified by cohort.

Table S7. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected 8-iso-PGF2α (ng/mL) in relation to biological, behavioral, and social factors, including only the latest oxidative stress measurement available in each cohort.

Table S8. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected 8-iso-PGF (ng/mL) in relation to biological, behavioral, and social factors removing the PROTECT cohort.

Table S9. Percent change (95% confidence interval) in urinary specific gravity-corrected 8-iso-PGF2α (ng/mL) in relation to biological, behavioral, and social factors, comparing inclusion of an indicator for cohort as a fixed effect versus random effect.

Highlights.

  • Oxidative stress biomarkers were elevated among pregnant people with higher socioeconomic disadvantage.

  • Associations were strongest for the chemical fraction of 8-iso-PGF2α.

  • Oxidative stress may link socioeconomic status to adverse pregnancy outcomes.

Acknowledgements

The authors wish to thank our ECHO colleagues, the medical, nursing, and program staff, as well as the children and families participating in the ECHO cohorts. We also acknowledge the contribution of the following ECHO program collaborators: ECHO Components - Coordinating Center: Duke Clinical Research Institute, Durham, North Carolina: Smith PB, Newby KL.

Funding Source

Research reported in this publication was supported by the Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health, under Award Numbers U2COD023375 (Coordinating Center), U24OD023382 (Data Analysis Center), U24OD023319 (PRO Core), and UG3OD023251, UH3OD023251, UG3OD023272, UH3OD023272, UG3OD023271, UH3OD023271, UG3023305, and UH3OD023305. This work was additionally supported by the Children’s Environmental Health and Disease Prevention Research Center (ES022848 and RD83543401), T32 National Institutes of Health Institution Training Grant Predoctoral Traineeship in Endocrine, Developmental, and Reproductive Toxicology (ES007326), United States Environmental Protection Agency (RD83543301), National Institute of Environmental Health Sciences (NIEHS) (P42ES017198, P50ES026049, P01ES022841, R01ES02705, R01ES025169, R01ES016863, P30ES019776, P30ES030284, and P30ES005022), and Intramural Research Program, NIEHS (ZIAES103313). G.L.M. is supported by the Vanderbilt Diabetes Research Center with funding from the National Institute of Diabetes and Digestive and Kidney Diseases (DK-20593).

Role of the Funding Source

The sponsor had no role in the study design; the collection, analysis, and interpretation of the data; the writing of the report; or in the decision to submit the article for publication.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Abbreviations:

8-iso-PGF2α

isoprostane-prostaglandin F2α

CI

confidence interval

CIOB

Chemicals in Our Bodies

HPA

hypothalamic-pituitary-adrenal

ICC

intraclass correlation coefficient

IKIDS

Illinois Kids Development Study

LOD

limit of detection

PGF2α

prostaglandin F2α

SD

standard deviation

SES

socioeconomic status

SpG

specific gravity

PROTECT

Puerto Rico Testsite for Exploring Contamination Threats

TIDES

The Infant Development and Environment Study

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Declaration of interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Ethical Approval

Each of these cohorts’ protocols was reviewed and approved by their local institutional review boards, and all cohort participants provided written, informed consent.

CRediT Author Statement

Stephanie M. Eick was responsible for funding acquisition, data cleaning and analysis, interpretation of results, writing-original draft, revisions and editing.

Sarah Dee Geiger contributed to data analysis, interpretation of results, writing-reviewing and editing.

Akram Alshawabkeh was responsible for funding acquisition, project administration, and writing-reviewing and editing.

Max Aung contributed to data analysis, interpretation of results, writing-reviewing and editing.

Emily Barrett contributed to project administration, and writing-reviewing and editing.

Nicole R. Bush contributed to project administration, and writing-reviewing and editing.

José F. Cordero was responsible for funding acquisition, project administration, and writing-reviewing and editing.

Kelly K. Ferguson contributed to data analysis, interpretation of results, writing-reviewing and editing.

John D. Meeker was responsible for funding acquisition, project administration, and writing-reviewing and editing.

Ginger L. Milne was responsible for the measurement of urinary oxidative stress biomarkers and contributed to writing-reviewing and editing.

Ruby HN Nguyen contributed to project administration, and writing-reviewing and editing.

Amy M. Padula contributed to data analysis, interpretation of results, writing-reviewing and editing.

Sheela Sathyanarayana contributed to project administration, and writing-reviewing and editing.

Barrett M. Welch contributed to data analysis, interpretation of results, writing-reviewing and editing.

Susan L. Schantz was responsible for funding acquisition, project administration, and writing-reviewing and editing.

Tracey J. Woodruff was responsible for funding acquisition, project administration, and writing-reviewing and editing.

Rachel Morello-Frosch contributed to data analysis and interpretation of results and was responsible for funding acquisition, project administration, and writing-reviewing and editing.

Data Availability Statement

The datasets for this manuscript are not publicly available because, per the NIH-approved ECHO Data Sharing Policy, ECHO-wide data have not yet been made available to the public for review/analysis. Requests to access the datasets should be directed to the ECHO Data Analysis Center, ECHO-DAC@rti.org.

References

  • 1.Lima SAM, El Dib RP, Rodrigues MRK, et al. Is the risk of low birth weight or preterm labor greater when maternal stress is experienced during pregnancy? A systematic review and meta-analysis of cohort studies. PLOS ONE. 2018;13(7):e0200594.doi: 10.1371/journal.pone.0200594 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dunlop AL, Essalmi AG, Alvalos L, et al. Racial and geographic variation in effects of maternal education and neighborhood-level measures of socioeconomic status on gestational age at birth: Findings from the ECHO cohorts. PLoS One. 2021;16(1):e0245064–e0245064. doi: 10.1371/journal.pone.0245064 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: Final Data for 2019. Natl Vital Stat Rep. 2021;70(2):1–51. [PubMed] [Google Scholar]
  • 4.Braveman PA, Heck K, Egerter S, et al. The role of socioeconomic factors in Black-White disparities in preterm birth. Am J Public Health. 2015;105(4):694–702. doi: 10.2105/AJPH.2014.302008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cutter SL, Boruff BJ, Shirley WL. Social Vulnerability to Environmental Hazards*. Social Science Quarterly. 2003;84(2):242–261. doi: 10.1111/1540-6237.8402002 [DOI] [Google Scholar]
  • 6.Morello-Frosch R, Shenassa ED. The environmental “riskscape” and social inequality: implications for explaining maternal and child health disparities. Environ Health Perspect. 2006;114(8):1150–1153. doi: 10.1289/ehp.8930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Eick SM, Goin DE, Cushing L, et al. Joint effects of prenatal exposure to per- and poly fluoroalkyl substances and psychosocial stressors on corticotropin-releasing hormone during pregnancy. Journal of Exposure Science & Environmental Epidemiology. Published online April 6, 2021. doi: 10.1038/s41370-021-00322-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ferguson KK, Rosen EM, Barrett ES, et al. Joint impact of phthalate exposure and stressful life events in pregnancy on preterm birth. Environment International. 2019;133:105254. doi: 10.1016/j.envint.2019.105254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Barrett ES, Padula AM. Joint Impact of Synthetic Chemical and Non-chemical Stressors on Children’s Health. Curr Environ Health Rep. 2019;6(4):225–235. doi: 10.1007/s40572-019-00252-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Padula AM, Monk C, Brennan PA, et al. A review of maternal prenatal exposures to environmental chemicals and psychosocial stressors-implications for research on perinatal outcomes in the ECHO program. J Perinatol. 2020;40(1):10–24. doi: 10.1038/s41372-019-0510-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Padula AM, Rivera-Núñez Z, Barrett ES. Combined Impacts of Prenatal Environmental Exposures and Psychosocial Stress on Offspring Health: Air Pollution and Metals. Curr Environ Health Rep. 2020;7(2):89–100. doi: 10.1007/s40572-020-00273-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ng PC. The fetal and neonatal hypothalamic–pituitary–adrenal axis. Arch Dis Child Fetal Neonatal Ed. 2000;82(3):F250. doi: 10.1136/fn.82.3.F250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.van ‘t Erve TJ, Kadiiska MB, London SJ, Mason RP. Classifying oxidative stress by F(2)-isoprostane levels across human diseases: A meta-analysis. Redox Biol. 2017;12:582–599. doi: 10.1016/j.redox.2017.03.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 2000;28(4):505–513. doi: 10.1016/s0891-5849(99)00264-6 [DOI] [PubMed] [Google Scholar]
  • 15.Cathey AL, Eaton JL, Ashrap P, et al. Individual and joint effects of phthalate metabolites on biomarkers of oxidative stress among pregnant women in Puerto Rico. Environment International. 2021;154:106565.doi: 10.1016/j.envint.2021.106565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Eick SM, Barrett ES, van ‘t Erve TJ, et al. Association between prenatal psychological stress and oxidative stress during pregnancy. Paediatr Perinat Epidemiol. 2018;32(4):318–326. doi: 10.1111/ppe.12465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Janczura M, Dropinski J, Gielicz A, et al. Potential roles of psychological and oxidative stress in insulin resistance: a cohort-based study. Diabetology & Metabolic Syndrome. 2020;12(1):58. doi: 10.1186/s13098-020-00566-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. Urinary Phthalate Metabolites and Biomarkers of Oxidative Stress in Pregnant Women: A Repeated Measures Analysis. Environmental Health Perspectives. 2015;123(3):210–216. doi: 10.1289/ehp.1307996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.van der Plas A, Pouly S, de La Bourdonnaye G, Baker G, Lüdicke F. Influence of smoking on levels of urinary 8-iso Prostaglandin F2α. Toxicology Reports.2019;6:18–25. doi: 10.1016/j.toxrep.2018.11.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Marseglia L, Manti S, D’Angelo G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014;16(1):378–400. doi: 10.3390/ijms16010378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Eick SM, Ferguson KK, Milne GL, et al. Repeated measures of urinary oxidative stress biomarkers and preterm birth in Puerto Rico. Free Radic Biol Med.2020;146:299–305. doi: 10.1016/j.freeradbiomed.2019.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ferguson KK, McElrath TF, Chen YH, Loch-Caruso R, Mukherjee B, Meeker JD. Repeated measures of urinary oxidative stress biomarkers during pregnancy and preterm birth. Am J Obstet Gynecol. 2015;212(2):208.e1–8.doi: 10.1016/j.ajog.2014.08.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ferguson KK, Meeker JD, McElrath TF, Mukherjee B, Cantonwine DE. Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies. Am J Obstet Gynecol. 2017;216(5):527.e1–527.e9.doi: 10.1016/j.ajog.2016.12.174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.National Institutes of Health. Environmental influences on Child Health Outcomes (ECHO) Program. Accessed January 4, 2022. https://www.nih.gov/research-training/environmental-influences-child-health-outcomes-echo-program [Google Scholar]
  • 25.Dorjgochoo T, Gao YT, Chow WH, et al. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself. Am J Clin Nutr. 2012;96(2):405–414. doi: 10.3945/ajcn.112.034918 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.van ‘t Erve TJ, Lih FB, Kadiiska MB, Deterding LJ, Eling TE, Mason RP. Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF2α/PGF2α ratio distinguishes chemical from enzymatic lipid peroxidation. Free Radical Biology and Medicine.2015;83:245–251. doi: 10.1016/j.freeradbiomed.2015.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Eick SM, Enright EA, Geiger SD, et al. Associations of Maternal Stress, Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFAS), and Demographic Risk Factors with Birth Outcomes and Offspring Neurodevelopment: An Overview of the ECHO.CA.IL Prospective Birth Cohorts. International Journal of Environmental Research and Public Health. 2021;18(2):742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ferguson KK, Rosario Z, McElrath TF, et al. Demographic risk factors for adverse birth outcomes in Puerto Rico in the PROTECT cohort. PLoS One. 2019;14(6):e0217770–e0217770. doi: 10.1371/journal.pone.0217770 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Swan SH, Sathyanarayana S, Barrett ES, et al. First trimester phthalate exposure and anogenital distance in newborns. Hum Reprod. 2015;30(4):963–972. doi: 10.1093/humrep/deu363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lee RT, Perez AD, Boykin CM, Mendoza-Denton R. On the prevalence of racial discrimination in the United States. PLoS One. 2019;14(1):e0210698–e0210698.doi: 10.1371/journal.pone.0210698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Eick SM, Meeker JD, Swartzendruber A, et al. Relationships between psychosocial factors during pregnancy and preterm birth in Puerto Rico. PLoS One. 2020;15(1):e0227976–e0227976. doi: 10.1371/journal.pone.0227976 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc. 2007;2(1):221–226. doi: 10.1038/nprot.2006.375 [DOI] [PubMed] [Google Scholar]
  • 33.Rosner B (Bernard A). Fundamentals of Biostatistics. Seventh edition. Boston:  : Brooks/Cole, Cengage Learning, [2011] ©2011; 2011. https://search.library.wisc.edu/catalog/9910098055302121 [Google Scholar]
  • 34.Basagaña X, Pedersen M, Barrera-Gómez J, et al. Analysis of multicentre epidemiological studies: contrasting fixed or random effects modelling and meta-analysis. International Journal of Epidemiology. 2018;47(4):1343–1354. doi: 10.1093/ije/dyy117 [DOI] [PubMed] [Google Scholar]
  • 35.Kuiper JR, O’Brien KM, Ferguson KK, Buckley JP. Urinary specific gravity measures in the U.S. population: Implications for the adjustment of non-persistent chemical urinary biomarker data. Environment International. 2021;156:106656.doi: 10.1016/j.envint.2021.106656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.O’Brien KM, Upson K, Cook NR, Weinberg CR. Environmental Chemicals in Urine and Blood: Improving Methods for Creatinine and Lipid Adjustment. Environ Health Perspect. 2016;124(2):220–227. doi: 10.1289/ehp.1509693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Eick SM, Meeker JD, Brown P, et al. Associations between socioeconomic status, psychosocial stress, and urinary levels of 8-iso-prostaglandin-F(2α) during pregnancy in Puerto Rico. Free Radic Biol Med. 2019;143:95–100.doi: 10.1016/j.freeradbiomed.2019.07.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Arogbokun O, Rosen E, Keil AP, et al. Maternal Oxidative Stress Biomarkers in Pregnancy and Child Growth from Birth to Age 6. The Journal of Clinical Endocrinology & Metabolism. 2021;106(5):1427–1436. doi: 10.1210/clinem/dgab018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Rosen EM, van ‘t Erve TJ, Boss J, et al. Urinary oxidative stress biomarkers and accelerated time to spontaneous delivery. Free Radic Biol Med. 2019;130:419–425. doi: 10.1016/j.freeradbiomed.2018.11.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Longini M, Perrone S, Vezzosi P, et al. Association between oxidative stress in pregnancy and preterm premature rupture of membranes. Clinical Biochemistry. 2007;40(11):793–797. doi: 10.1016/j.clinbiochem.2007.03.004 [DOI] [PubMed] [Google Scholar]
  • 41.Peter Stein T, Scholl TO, Schluter MD, et al. Oxidative stress early in pregnancy and pregnancy outcome. null. 2008;42(10):841–848. doi: 10.1080/10715760802510069 [DOI] [PubMed] [Google Scholar]
  • 42.Mestan K, Matoba N, Arguelles L, et al. Cord blood 8-isoprostane in the preterm infant. Early Hum Dev. 2012;88(8):683–689.doi: 10.1016/j.earlhumdev.2012.02.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Anto EO, Roberts P, Coall DA, et al. Suboptimal health pregnant women are associated with increased oxidative stress and unbalanced pro- and antiangiogenic growth mediators: a cross-sectional study in a Ghanaian population. Free Radical Research. 2020;54(1):27–42. doi: 10.1080/10715762.2019.1685668 [DOI] [PubMed] [Google Scholar]
  • 44.Van’t Erve TJ, Lih FB, Jelsema C, et al. Reinterpreting the best biomarker of oxidative stress: The 8-iso-prostaglandin F2α/prostaglandin F2α ratio shows complex origins of lipid peroxidation biomarkers in animal models. Free Radic Biol Med. 2016;95:65–73. doi: 10.1016/j.freeradbiomed.2016.03.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.van ‘t Erve TJ, Lih FB, Kadiiska MB, Deterding LJ, Mason RP. Elevated plasma 8-iso prostaglandin F2α levels in human smokers originate primarily from enzymatic instead of non-enzymatic lipid peroxidation. Free Radical Biology and Medicine. 2018;115:105–112. doi: 10.1016/j.freeradbiomed.2017.11.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.van TETJ, Rosen EM, Barrett ES, et al. Phthalates and Phthalate Alternatives Have Diverse Associations with Oxidative Stress and Inflammation in Pregnant Women. Environ Sci Technol. 2019;53(6):3258–3267.doi: 10.1021/acs.est.8b05729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kim JY, Lee JH, Song HJ, Kim DG, Yim YS. Relationships between Psychosocial Difficulties and Oxidative Stress Biomarkers in Women Subject to Intimate Partner Violence. Health & Social Work. 2017;42(1):41–47. doi: 10.1093/hsw/hlw053 [DOI] [PubMed] [Google Scholar]
  • 48.Boeck C, Gumpp AM, Koenig AM, Radermacher P, Karabatsiakis A, Kolassa IT. The Association of Childhood Maltreatment With Lipid Peroxidation and DNA Damage in Postpartum Women. Frontiers in Psychiatry. 2019;10:23. doi: 10.3389/fpsyt.2019.00023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Szanton SL, Rifkind JM, Mohanty JG, et al. Racial discrimination is associated with a measure of red blood cell oxidative stress: a potential pathway for racial health disparities. Int J Behav Med. 2012;19(4):489–495. doi: 10.1007/s12529-011-9188-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43–46. [PubMed] [Google Scholar]
  • 51.Gopaul NK, Halliwell B, Änggård EE. Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. null. 2000;33(2):115–127. doi: 10.1080/10715760000300671 [DOI] [PubMed] [Google Scholar]
  • 52.Richelle M, Turini ME, Guidoux R, Tavazzi I, Métairon S, Fay LB. Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Letters. 1999;459(2):259–262. doi: 10.1016/S0014-5793(99)01259-4 [DOI] [PubMed] [Google Scholar]
  • 53.Helmersson J, Basu S. F2-isoprostane and prostaglandin F2αmetabolite excretion rate and day to day variation in healthy humans. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 2001;65(2):99–102. doi: 10.1054/plef.2001.0295 [DOI] [PubMed] [Google Scholar]
  • 54.Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990;87(23):9383–9387. doi: 10.1073/pnas.87.23.9383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Klawitter J, Haschke M, Shokati T, Klawitter J, Christians U. Quantification of 15-F2tisoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared. Rapid Communications in Mass Spectrometry. 2011;25(4):463–468. doi: 10.1002/rcm.4871 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Figure S1. Flowchart indicating participant selection into final analytic sample.

Figure S2. Directed acyclic graph for the relationships between biological, behavioral, and social factors and biomarkers of oxidative stress.

Table S1. Sample size across individual exposure-outcome combinations for adjusted repeated measures analysis.

Table S2. Distribution of biological, behavioral, and social factors across individual cohorts.

Table S3. Distribution of urinary levels of subject-specific oxidative stress biomarkers corrected with specific gravity (ng/mL) across individual cohorts.

Table S4. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected oxidative stress biomarker concentrations (ng/mL) in relation to biological, behavioral, and social factors.

Table S5. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected oxidative stress biomarker concentrations (ng/mL) in relation to biological, behavioral, and social factors. Models are minimally adjusted for cohort.

Table S6. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected 8-iso-PGF2α (ng/mL) in relation to biological, behavioral, and social factors stratified by cohort.

Table S7. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected 8-iso-PGF2α (ng/mL) in relation to biological, behavioral, and social factors, including only the latest oxidative stress measurement available in each cohort.

Table S8. Repeated measures analyses: percent change (95% confidence interval) in urinary specific gravity-corrected 8-iso-PGF (ng/mL) in relation to biological, behavioral, and social factors removing the PROTECT cohort.

Table S9. Percent change (95% confidence interval) in urinary specific gravity-corrected 8-iso-PGF2α (ng/mL) in relation to biological, behavioral, and social factors, comparing inclusion of an indicator for cohort as a fixed effect versus random effect.

Data Availability Statement

The datasets for this manuscript are not publicly available because, per the NIH-approved ECHO Data Sharing Policy, ECHO-wide data have not yet been made available to the public for review/analysis. Requests to access the datasets should be directed to the ECHO Data Analysis Center, ECHO-DAC@rti.org.

RESOURCES